AORT vs CNMD
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Aug 22, 2026
AORT
CNMD
Investment Advisor Scores
CNMD
AI Analyst Insights
Detailed Metrics Comparison
| Metric | AORT | CNMD | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 204.0816 | 27.1739 | CNMD |
| PEG Ratio | 181.5 | 1.8437 | CNMD |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 11.3% | 0.3% | AORT |
| Earnings Growth | 0.0% | 11.2% | CNMD |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 39.0/100 | 45.0/100 | CNMD |
| Profit Margin | -0.7% | 4.1% | CNMD |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | SELL | HOLD | CNMD |
Relative Price Performance (Last 90 Days)
Current Technical Phase
AORT
MarkupPrice above SMA50, rising 50-day trend (10.1% over 20 days), RSI 57
CNMD
MarkupPrice above SMA50, rising 50-day trend (14.3% over 20 days), RSI 66
Fundamentals Snapshot
| Metric | AORT | CNMD |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 35.9 | 10.7 |
| Trailing P/E | — | 27.8 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.1% | 0.0% |
| Gross Margin | 0.6% | 0.6% |
| Operating Margin | 0.1% | 0.1% |
| EPS | -0.06 | 1.85 |
| Dividend Yield | — | 0.00% |